Clinical Trial Update: Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 safety trial evaluated autologous bone marrow stromal cells modified with hepatocyte growth factor for treating silicosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Silicosis

Drugs mentioned

• Autologous bone marrow stromal cells modified by hepatocyte growth factor

Snippet

Sponsor: Wei Yu | Conditions: Silicosis | Phase 1, Phase 2 | Status: COMPLETED